| Andrew Daniel Messa, MD | |
|
1420 London Rd, Suite 101, Duluth, MN 55805-2433 | |
| (218) 724-7363 | |
| (218) 724-6199 |
| Full Name | Andrew Daniel Messa |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 1420 London Rd, Duluth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225064959 | NPI | - | NPPES |
| 644756200 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 43542 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Daniel Messa, MD 1420 London Rd, Suite 101, Duluth, MN 55805-2433 Ph: (218) 724-7363 | Andrew Daniel Messa, MD 1420 London Rd, Suite 101, Duluth, MN 55805-2433 Ph: (218) 724-7363 |
News Archive
athenahealth, Inc., a leading provider of web-based practice management, electronic health record, and patient communication services to medical groups, today announced that CHRISTUS Health, a leading Texas-based, not-for-profit, healthcare company that includes more than 50 hospitals and healthcare facilities in nine states, has selected athenahealth's full suite of web-based services for its rapidly growing CHRISTUS Provider Network (CPN) which is currently comprised of over 150 medical providers across more than 40 clinics in Arkansas, Louisiana, and Texas.
In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.
Sucampo Pharmaceuticals, Inc. and Abbott today reported data from a phase 3 clinical efficacy trial in 124 Japanese chronic idiopathic constipation patients as well as from a phase 3 long-term safety trial in an additional 209 Japanese CIC patients.
FibroGen, Inc. today announced initiation of a phase 2 study to compare the efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), with placebo in reversing liver fibrosis (scarring of the liver) due to chronic infection with hepatitis B virus (HBV).
The January 2013 issue of Neurosurgical Focus is dedicated to the science of neurosurgical practice and is edited by Drs. Anthony L. Asher (Carolina Neurosurgery and Spine Associates & Carolinas Medical Center, Charlotte, NC), Paul C. McCormick (Columbia University College of Physicians and Surgeons, New York, NY), and Douglas Kondziolka (New York University, New York, NY).
› Verified 9 days ago
Dr. Sarah Layne Crandall, M.D., Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1420 London Rd Ste 101, Duluth, MN 55805 Phone: 218-724-7363 | |
Dr. Edgar F. Saldana, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 324 W Superior St Ste 100, Duluth, MN 55802 Phone: 218-215-8990 Fax: 218-217-4371 | |
Dr. Andrew Baertsch, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1420 London Rd, Suite 101, Duluth, MN 55805 Phone: 218-724-7363 Fax: 218-724-6199 | |
Dr. Wade Daniel Kubat, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1012 E 2nd St, Duluth, MN 55805 Phone: 218-249-7910 Fax: 218-249-7999 | |
Mr. Thomas Jon Rishavy, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1420 London Rd, Suite 101, Duluth, MN 55805 Phone: 218-724-7363 Fax: 218-724-6199 | |
Dean Herbert Weber, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1420 London Rd, Suite 101, Duluth, MN 55805 Phone: 218-724-7363 Fax: 218-724-6199 |